scholarly journals Similar Intrapatient Blood Glucose Variability with LY2963016 and Lantus® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation

2018 ◽  
Vol 9 (4) ◽  
pp. 1469-1476 ◽  
Author(s):  
Hiroshi Nishiyama ◽  
Tomotaka Shingaki ◽  
Yumi Suzuki ◽  
Liza L. Ilag
2020 ◽  
Vol 32 (4) ◽  
pp. 490-497
Author(s):  
Walid Shehab-Eldin ◽  
Ahmed Al-ashmawy ◽  
Mahmoud Kamel ◽  
Nesrin Elhelbawy ◽  
Alaaeldin Dawood ◽  
...  

Author(s):  
Dario Pitocco ◽  
Mauro Di Leo ◽  
Linda Tartaglione ◽  
Emanuele Gaetano Rizzo ◽  
Salvatore Caputo ◽  
...  

Background: Diabetic Ketoacidosis (DKA) is one of the most commonly encountered diabetic complication emergencies. It typically affects people with type 1 diabetes at the onset of the disease. It can also affect people with type 2 diabetes, although this is uncommon. Methods: Research and online content related to diabetes online activity is reviewed. DKA is caused by a relative or absolute deficiency of insulin and elevated levels of counter regulatory hormones. Results: Goals of therapy are to correct dehydration, acidosis and to reverse ketosis, gradually restoring blood glucose concentration to near normal. Conclusion: Furthermore it is essential to monitor potential complications of DKA and if necessary, to treat them and any precipitating events.


Sign in / Sign up

Export Citation Format

Share Document